Skip to Content

Disclaimer

Disclaimer
MDS makes every effort to publish accurate information on the website. "Google Translate" is provided as a free tool for visitors to read content in one's native language. Translations are not guaranteed to be 100% accurate. Neither MDS nor its employees assume liability for erroneous translations of website content.

 

International Congress of Parkinson’s Disease and Movement Disorders ®

Congress

Therapeutic Plenary Session 1102

Non-Motor Features of Parkinson's Disease

Sunday, October 4, 2026
10:30 - 12:00 | Grand Ballroom, Level 1

At the end of this session, participants should be aware of current approaches to management of motor symptoms in early and late stages of Parkinson's disease, including medications, non-pharmacological approaches, device-assisted infusions, and surgical interventions.

Chairs:

Jennifer Goldman, USA
Andrew Siderowf, USA

Presenters:

Current Treatments for Sleep and Fatigue
Ambra Stefani, Austria

Current Treatments for Pain and Autonomic Dysfunction
Horacio Kaufmann, USA

Current and Future Treatment of Cognitive and Behavioral Features of Parkinson’s Disease
Simon Lewis, Australia

CSPC Liaison(s):

Andrew Siderowf, USA

Learning Objectives

At the conclusion of this session, participants should be better able to:

  1. Know current and emerging treatments for sleep and fatigue in Parkinson's disease
  2. Be aware of treatments for pain and autonomic dysfunction in Parkinson's disease and their indications
  3. Review the strengths and weaknesses of current therapies for cognitive and behavioral problems in Parkinson's disease and be aware of emerging therapies

Recommended Audience

Clinician / General Neurology
Fellow / Resident / Student
Health Professional (non-physician)
Industry

Education Level

Beginner / Foundational
Intermediate / Experienced